Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 1

Results: 35

Automated chemotherapy compounding: Process optimization for the preparation of admixture containing high-dose of cyclophosphamide.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 208, doi. 10.1177/10781552221130012

By:

Perego, Gianluca;
Longobardo, Giorgia;
Baldisserotto, Anna;
Feliciani, Matteo;
Fazio, Maria

Publication type:

Article

Review of novel and supplemental approvals of the targeted cancer drugs by the Food and Drug Administration in 2021.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 191, doi. 10.1177/10781552221112015

By:

Kandemir, Esin Aysel

Publication type:

Article

Understanding the differences in outcome between CART studies as second-line treatment in aggressive lymphoma.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 183, doi. 10.1177/10781552221110806

By:

Dada, Reyad

Publication type:

Article

Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myeloma.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 170, doi. 10.1177/10781552221107850

By:

Shah, Bhavesh;
Gray, Joy;
Abraham, Ivo;
Chang, Melody

Publication type:

Article

Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 246, doi. 10.1177/10781552221102591

By:

Pehlivan, Umur A;
Gürkan, Emel;
Açar, İbrahim H;
Bıçakcı, Yunus K

Publication type:

Article

Avascular necrosis during alectinib treatment: Case report.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 242, doi. 10.1177/10781552221102370

By:

Gürsoy, Pınar

Publication type:

Article

Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 239, doi. 10.1177/10781552221102318

By:

Moore, Donald C;
Eagers, Keren A;
Janes, Amanda;
Pineda-Roman, Mauricio

Publication type:

Article

Trousseau's syndrome in a non-small cell lung cancer patient aggravated by pembrolizumab.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 233, doi. 10.1177/10781552221102311

By:

Zhao, Lihong;
Zheng, Hong;
Zhu, Liqin;
Jiang, Ping

Publication type:

Article

Vortex keratopathy associated with ribociclib.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 230, doi. 10.1177/10781552221101799

By:

Türkel, Alper;
Özdoğan, Sibel;
Yekedüz, Emre;
Şeyran, Erdoğan;
Karaçin, Cengiz;
Ateş, Öztürk

Publication type:

Article

Erythema nodosum after azacitidine in a patient with acute myeloid leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 226, doi. 10.1177/10781552221098422

By:

Nasrollahi, Elham;
Giubellino, Alessio;
Rashidi, Armin

Publication type:

Article

Lichenoid drug eruption associated with imatinib mesylate therapy.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 252, doi. 10.1177/10781552221096846

By:

Alexandris, Dimitrios;
Alevizopoulos, Nektarios;
Marinos, Leonidas;
Kanellis, Georgios;
Gakiopoulou, Charikleia

Publication type:

Article

Acute pancreatitis secondary to tamoxifen-associated hypertriglyceridemia: A clinical update.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 218, doi. 10.1177/10781552221093969

By:

Goraya, Muhammad Hassan Naeem;
Abbasi, Ehsan ul Haq;
Amin, Muhammad Kashif;
Inayat, Faisal;
Ashraf, Muhammad Junaid;
Qayyum, Mahrukh;
Hussain, Nadeem;
Nawaz, Gul;
Zaman, Muhammad Adnan;
Malik, Adnan

Publication type:

Article

Pulmonary embolism and bradycardia in a NSCLC patient treated with crizotinib for a rare mutation.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 211, doi. 10.1177/10781552221091595

By:

Shi, Yunjing;
Qiu, Zeping;
Ding, Yongjie;
Chen, Yanjia;
Zhang, Andi;
Jin, Wei

Publication type:

Article

The design, implementation and evaluation of hybrid cancer clinic simulations: Escaping the norm.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 162, doi. 10.1177/10781552211063811

By:

Norville, Kathryn;
Philip, Ashok;
Halford, Zachery

Publication type:

Article

Daratumumab-based therapies in transplant-ineligible patients with untreated multiple myeloma and hepatic dysfunction: A systematic review of subgroup analyses.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 155, doi. 10.1177/10781552211062144

By:

Gil-Sierra, Manuel David;
Briceño-Casado, Maria del Pilar;
Fénix-Caballero, Silvia;
Alegre-Del Rey, Emilio Jesús;
de la Lastra-Romero, Catalina Alarcón;
Sánchez-Hidalgo, Marina

Publication type:

Article

Evaluation and clinical impact of a pharmacist-led, interdisciplinary service focusing on education, monitoring and toxicity management of immune checkpoint inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 145, doi. 10.1177/10781552211061133

By:

Myers, Glenn;
Stevens, Jonathan;
Flewelling, Andrew;
Richard, Jacqueline;
London, Meagan

Publication type:

Article

Effectiveness and safety of pembrolizumab monotherapy in patients with locally advanced or metastatic non-small-cell lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 138, doi. 10.1177/10781552211061117

By:

Tamayo-Bermejo, Rocio;
del Rio-Valencia, Juan Carlos;
Mora-Rodriguez, Beatriz;
Muñoz-Castillo, Isabel

Publication type:

Article

High dose valacyclovir for cytomegalovirus prophylaxis following allogeneic hematopoietic cell transplantation.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 130, doi. 10.1177/10781552211060479

By:

Hawks, Kelly G;
Fegley, Amanda;
Sabo, Roy T;
Roberts, Catherine H;
Toor, Amir A

Publication type:

Article

Retrospective analysis of failures of ambulatory elastomeric pumps containing 5-FU in a hospital pharmacy unit.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 125, doi. 10.1177/10781552211060290

By:

Chefchaouni, Ali Cherif;
Ouedraogo, Jean-Marie;
Bechar, Hafsa;
Belahcen, Mohammed Jaouad;
Rahali, Younes

Publication type:

Article

Retrospective evaluation of sodium acetate use for urine alkalinization in patients receiving high dose methotrexate.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 119, doi. 10.1177/10781552211060287

By:

Perkey, Cassandra L;
Flynn, Laura A;
Lentz, Katie;
Butler, Sara

Publication type:

Article

Patients' knowledge and awareness of safe handling of oral anticancer agents at Sultan Qaboos University Hospital in Oman.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 112, doi. 10.1177/10781552211056238

By:

Hassan, Moataz M;
Al-Marzooq, Dhabya;
Al-Habsi, Hanan;
Al-Hashar, Amna;
Al-Khabori, Murtadha;
Al-Moundhri, Mansour;
Al-Zakwani, Ibrahim

Publication type:

Article

Asparaginase activity monitoring and management of asparaginase hypersensitivity reactions in Canada.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 105, doi. 10.1177/10781552211055405

By:

Pike, Meghan;
Kulkarni, Ketan;
MacDonald, Tamara

Publication type:

Article

Tolerability of palbociclib in younger and older patients with advanced breast cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 96, doi. 10.1177/10781552211053639

By:

Dennison, Taylor;
Heiling, Hillary;
Deal, Allison;
Brunk, Kelly;
Kemper, Ryan;
Crona, Daniel J;
Faso, Aimee

Publication type:

Article

Application of the Failure Mode and Effects Analysis (FMEA) to identify vulnerabilities and opportunities for improvement prior to implementing a computerized prescription order entry (CPOE) system in a university hospital oncology clinic.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 88, doi. 10.1177/10781552211053253

By:

Joly-Mischlich, Thomas;
Maltais, Serge;
Tétu, Amélie;
Delorme, Marie-Noëlle;
Boilard, Brigitte;
Pavic, Michel

Publication type:

Article

Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 83, doi. 10.1177/10781552211053251

By:

Lasala, Ruggero;
Santoleri, Fiorenzo;
Zanon, Davide;
Romagnoli, Alessia;
Abrate, Paolo;
Costantini, Alberto;
Musicco, Felice

Publication type:

Article

Development and use of an innovative Gap Finding Tool to create a Pharmaceutical Care Model within a paediatric oncology setting.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 74, doi. 10.1177/10781552211053249

By:

Falzon, Sephorah;
Galea, Nathalie;
Calvagna, Victor;
Pham, Jennifer T;
Grech, Louise;
Azzopardi, Lilian M

Publication type:

Article

Retrospective assessment of chemotherapy/biotherapy toxicity in a Hispanic/Latinx population versus published study population.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 66, doi. 10.1177/10781552211053248

By:

Leidy, Sara B;
Hull, Lauren R;
Macik, Monica R;
Gonzalvo, Jasmine D;
Weddle, Kellie J

Publication type:

Article

Evaluating the effects of duloxetine on prophylaxis of oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: A randomized double-blind placebo controlled clinical trial.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 60, doi. 10.1177/10781552211052646

By:

Rokhsareh, Soufi;
Haghighi, Shirin;
Tavakoli-Ardakani, Maria

Publication type:

Article

Impact of a Pharmacist-Led Hypertension Management Program for Oral Chemotherapy in a Specialty Pharmacy Setting.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 52, doi. 10.1177/10781552211052636

By:

Wang, Gabriel;
Truong, Havan;
Dang, Richard

Publication type:

Article

The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapy.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 45, doi. 10.1177/10781552211052635

By:

Peaytt, Rachel;
Parsons, Laura Beth;
Siler, Darby;
Matthews, Rachel;
Li, Belinda;
Bell, David;
Bachier, Carlos;
Pantin, Jeremy;
Berdeja, Jesus;
Flinn, Ian;
Donnellan, William;
Battiwalla, Minoo

Publication type:

Article

Imatinib plasma levels in patients with chronic myeloid leukaemia under routine clinical practice conditions.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 40, doi. 10.1177/10781552211052535

By:

Del Rosario García, Betel;
González García, Iris;
Viña Romero, María Micaela;
González García, Jonathan;
Ramos Díaz, Ruth;
Mourani Padrón, Ivette;
Lakhwani Lakhwani, Sunil;
Nazco Casariego, Gloria Julia;
Gutiérrez Nicolás, Fernando

Publication type:

Article

Evaluation of denosumab in adult oncology patients for the prevention of skeletal related events across a large academic health system.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 33, doi. 10.1177/10781552211052514

By:

Sproat, Michelle R.;
Burton, Bradley;
Burdalski, Catherine;
Porter, Timothy;
Proctor, Celia;
Goldenhorn, Michael;
Andoh, Kofi;
Gilmore, Steven

Publication type:

Article

Patient satisfaction and behavioural intention in using the home medication delivery service in an ambulatory oncology centre.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 22, doi. 10.1177/10781552211050873

By:

Leow, Jo Lene;
Lin, Keegan;
Chew, Lita

Publication type:

Article

A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 14, doi. 10.1177/10781552211050106

By:

Olazagasti, Coral;
Lee, Chung-Shien;
Liu, Angel;
Stefanov, Dimitre;
Cheng, Kit

Publication type:

Article

Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 1, p. 5, doi. 10.1177/10781552211049144

By:

Ockeloen, Charlotte W;
Raaijmakers, Aron;
Hijmans-van der Vegt, Manon;
Bierau, Jörgen;
de Vos-Geelen, Judith;
Willemsen, Annelieke ECAB;
van den Bosch, Bianca JC;
Coenen, Marieke JH

Publication type:

Article